CARDIAC AMYLOIDOSIS OF AL AND ATTR TYPES IN ELDERLY VIETNAMESE PATIENTS: A REPORT OF TWO CLINICAL CASES
Main Article Content
Abstract
Amyloidosis is a systemic infiltrative disease that affects multiple organs. To date, more than 50 types of proteins have been identified as contributors to the formation of amyloid fibrils and deposits that cause organ dysfunction. In elderly individuals, the clinical manifestations of amyloidosis are often nonspecific and can be misdiagnosed as other conditions such as heart failure, acute coronary syndrome, or malignancies. This article presents two cases of cardiac amyloidosis—AL and ATTR types—in elderly Vietnamese patients. The clinical and paraclinical data from these cases may aid clinicians in recognizing cardiac amyloidosis in daily practice. Additionally, the article provides an updated overview of the diagnosis and management of cardiac amyloidosis.
Article Details
Keywords
elderly patient, amyloidosis tim, infiltrative diseases
References
2. Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, et al. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. European heart journal. 2021;42(16):1554-68.
3. Kittleson MM, Ruberg FL, Ambardekar AV, Brannagan TH, Cheng RK, Clarke JO, et al. 2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: a report of the American College of Cardiology Solution Set Oversight Committee. Journal of the American College of Cardiology. 2023;81(11):1076-126.
4. Martinez-Naharro A, Hawkins PN, Fontana M. Cardiac amyloidosis. Clinical Medicine. 2018;18(2):s30-s5.
5. Moody WE, Turvey-Haigh L, Knight D, Coats CJ, Cooper RM, Schofield R, et al. British Society of Echocardiography guideline for the transthoracic echocardiographic assessment of cardiac amyloidosis. Echo Research & Practice. 2023;10(1):13.